WikiDer > Motexafin gadolinium

Motexafin gadolinium
Klinik ma'lumotlar
ATC kodi	yo'q;
Identifikatorlar
CAS raqami	156436-89-4 ;
PubChem CID	158385;
ChemSpider	139341 ;
UNII	6433A42F4F;
KEGG	D05080 ;
ChEBI	CHEBI: 50161 ;
CompTox boshqaruv paneli (EPA)	DTXSID4037083 ;
Kimyoviy va fizik ma'lumotlar
Formula	C52H72GdN5O14
Molyar massa	1148.42 g · mol−1
3D model (JSmol)	Interaktiv rasm;
	Jilmayganlar CCC1 = C (C2 = CC3 = NC (= CN = C4C = C (C (= CC4 = NC = C5C (= C (C (= N5) C = C1 [N-] 2) CCCO) C) OCCOCCOCCOC) OCCOCCOCCOC ) C (= C3CCCO) C) CC.CC (= O) [O -]. CC (= O) [O -]. [Gd + 3];
	InChI InChI = 1S / C48H66N5O10.2C2H4O2.Gd / c1-7-35-36 (8-2) 40-28-42-38 (12-10-14-55) 34 (4) 46 (53-42) 32- 50-44-30-48 (63-26-24-61-22-20-59-18-16-57-6) 47 (62-25-23-60-21-19-58-17-15-) 56-5) 29-43 (44) 49-31-45-33 (3) 37 (11-9-13-54) 41 (52-45) 27-39 (35) 51-40; 2 * 1- 2 (3) 4; / h27-32,54-55H, 7-26H2,1-6H3; 2 * 1H3, (H, 3,4); / q-1 ;;; + 3 / p-2 / b39 -27-, 40-28-, 41-27-, 42-28-, 45-31-, 46-32-, 49-31 +, 49-43 +, 50-32 +, 50-44 + ;; ; ; Kalit: VAZLWPAHMORDGR-WRIGXHCHSA-L ;
	(tasdiqlash)

Motexafin gadolinium

Motexafin gadolinium (taklif qilingan savdo nomi Xtsitrin) ning inhibitori hisoblanadi tioredoksin reduktaza va ribonukleotid reduktaza. Bu iloji boricha taklif qilingan kimyoviy terapevtik vosita davolashda miya metastazlari.^[1]

Tarix

2006 yil 9-mayda yangi dori-darmonga ariza yuborildi Qo'shma Shtatlar Oziq-ovqat va dori-darmonlarni boshqarish (FDA) tomonidan Pharmacyclics, Inc.^[2]

2007 yil dekabrda FDA motexafin gadolinium uchun ma'qullanmagan xat berdi.^[3]

Bu biokimyo maqola a naycha. Siz Vikipediyaga yordam berishingiz mumkin uni kengaytirish.

Klinik ma'lumotlar

ATC kodi	yo'q
Identifikatorlar
CAS raqami	156436-89-4^Y
PubChem CID	158385
ChemSpider	139341^Y
UNII	6433A42F4F
KEGG	D05080^Y
ChEBI	CHEBI: 50161^Y
CompTox boshqaruv paneli (EPA)	DTXSID4037083
Kimyoviy va fizik ma'lumotlar
Formula	C₅₂H₇₂GdN₅O₁₄
Molyar massa	1148.42 g · mol⁻¹
3D model (JSmol)	Interaktiv rasm
Jilmayganlar CCC1 = C (C2 = CC3 = NC (= CN = C4C = C (C (= CC4 = NC = C5C (= C (C (= N5) C = C1 [N-] 2) CCCO) C) OCCOCCOCCOC) OCCOCCOCCOC ) C (= C3CCCO) C) CC.CC (= O) [O -]. CC (= O) [O -]. [Gd + 3]
InChI InChI = 1S / C48H66N5O10.2C2H4O2.Gd / c1-7-35-36 (8-2) 40-28-42-38 (12-10-14-55) 34 (4) 46 (53-42) 32- 50-44-30-48 (63-26-24-61-22-20-59-18-16-57-6) 47 (62-25-23-60-21-19-58-17-15-) 56-5) 29-43 (44) 49-31-45-33 (3) 37 (11-9-13-54) 41 (52-45) 27-39 (35) 51-40; 2 * 1- 2 (3) 4; / h27-32,54-55H, 7-26H2,1-6H3; 2 * 1H3, (H, 3,4); / q-1 ;;; + 3 / p-2 / b39 -27-, 40-28-, 41-27-, 42-28-, 45-31-, 46-32-, 49-31 +, 49-43 +, 50-32 +, 50-44 + ;; ;^Y Kalit: VAZLWPAHMORDGR-WRIGXHCHSA-L^Y
(tasdiqlash)